loadpatents
name:-0.023062944412231
name:-0.019996881484985
name:-0.005964994430542
Tai; Kuninori Patent Filings

Tai; Kuninori

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tai; Kuninori.The latest application filed is for "heterocyclic compounds for treating or preventing disorders caused by reduced neurotransmission of serotonin, norephnephrine or ".

Company Profile
5.22.24
  • Tai; Kuninori - Osaka JP
  • TAI; Kuninori - Tokushima-shi JP
  • Tai; Kuninori - Tokushima JP
  • TAI; Kuninori - Osaka-shi JP
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods of treating anxiety by administering a substituted quinolone
Grant 11,273,168 - Ito , et al. March 15, 2
2022-03-15
Heterocyclic Compounds For Treating Or Preventing Disorders Caused By Reduced Neurotransmission Of Serotonin, Norephnephrine Or
App 20200281951 - ITO; Nobuaki ;   et al.
2020-09-10
Cyanotriazole compounds
Grant 10,626,095 - Sato , et al.
2020-04-21
Method of treating disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine
Grant 10,603,331 - Ito , et al.
2020-03-31
Heterocyclic Compounds For Treating Or Preventing Disorers Caused By Reduced Neurotransmission Of Serotonin, Norephnephrine Or Dopamine
App 20190142852 - ITO; Nobuaki ;   et al.
2019-05-16
N,n-substituted 3-aminopyrrolidine Compounds Useful As Monoamines Reuptake Inhibitors
App 20180258038 - KURIMURA; Muneaki ;   et al.
2018-09-13
Method for treating depression and/or depression status with substituted quinoxaline compounds
Grant 10,064,879 - Ito , et al. September 4, 2
2018-09-04
N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
Grant 10,000,450 - Kurimura , et al. June 19, 2
2018-06-19
Heterocyclic Compounds For Treating Or Preventing Disorers Caused By Reduced Neurotransmission Of Serotonin, Norephnephrine Or Dopamine
App 20170224713 - ITO; Nobuaki ;   et al.
2017-08-10
N,n-substituted 3-aminopyrrolidine Compounds Useful As Monoamines Reuptake Inhibitors
App 20170166524 - KURIMURA; Muneaki ;   et al.
2017-06-15
N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
Grant 9,611,214 - Kurimura , et al. April 4, 2
2017-04-04
Cyanotriazole Compounds
App 20160229816 - SATO; Seiji ;   et al.
2016-08-11
Heterocyclic Compounds For Treating Or Preventing Disorers Caused By Reduced Neurotransmission Of Serotonin, Norephnephrine Or Dopamine
App 20160058757 - ITO; Nobuaki ;   et al.
2016-03-03
Substituted quinoxalines compounds
Grant 9,090,572 - Ito , et al. July 28, 2
2015-07-28
6,7-dihydroimidazo [2,1-b] [1,3]oxazine bactericides
Grant 9,051,333 - Kawano , et al. June 9, 2
2015-06-09
Nitrogen-containing Compounds And Pharmaceutical Compositions Thereof For The Treatment Of Atrial Fibrillation
App 20140343277 - TAIRA; Shinichi ;   et al.
2014-11-20
N,n-substituted 3-aminopyrrolidine Compounds Useful As Monoamines Reuptake Inhibitors
App 20140288065 - KURIMURA; Muneaki ;   et al.
2014-09-25
Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation
Grant 8,822,453 - Matsumura , et al. September 2, 2
2014-09-02
N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
Grant 8,815,871 - Kurimura , et al. August 26, 2
2014-08-26
Benzodiazepine compound and pharmaceutical composition
Grant 8,664,217 - Oshima , et al. March 4, 2
2014-03-04
6,7-DIHYDROIMIDAZO [2,1-b] [1,3]OXAZINE BACTERICIDES
App 20140031342 - Kawano; Yoshikazu ;   et al.
2014-01-30
Heterocyclic Compounds For Treating Or Preventing Disorders Caused By Reduced Neurotransmission Of Serotonin, Norephnephrine Or Dopamine
App 20130261081 - Ito; Nobuaki ;   et al.
2013-10-03
N,n-substituted 3-aminopyrrolidine Compounds Useful As Monoamines Reuptake Inhibitors
App 20130203750 - KURIMURA; Muneaki ;   et al.
2013-08-08
N, N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
Grant 8,420,623 - Kurimura , et al. April 16, 2
2013-04-16
Benzodiazepine Compound And Pharmaceutical Composition
App 20130040941 - Oshima; Kunio ;   et al.
2013-02-14
Benzodiazepine compound and pharmaceutical composition
Grant 8,338,406 - Oshima , et al. December 25, 2
2012-12-25
Aromatic Compound
App 20120238750 - FUKUSHIMA; Tae ;   et al.
2012-09-20
Nitrogen-containing Compounds And Pharmaceutical Compositions Thereof For The Treatment Of Atrial Fibrillation
App 20120225866 - Oshima; Kunio ;   et al.
2012-09-06
Aromatic compounds for suppressing the generation of collagen
Grant 8,188,277 - Fukushima , et al. May 29, 2
2012-05-29
N-n-substituted 3-aminopyrrolidine Compounds Useful As Monoamines Reuptake Inhibitors
App 20120065162 - KURIMURA; Muneaki ;   et al.
2012-03-15
N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
Grant 8,084,442 - Kurimura , et al. December 27, 2
2011-12-27
Benzodiazepine Compound And Pharmaceutical Composition
App 20100331317 - Oshima; Kunio ;   et al.
2010-12-30
N,n-substituted 3-aminopyrrolidine Compounds Useful As Monoamines Reuptake Inhibitors
App 20090088406 - Kurimura; Muneaki ;   et al.
2009-04-02
Aromatic Compounds
App 20070270422 - Fukushima; Tae ;   et al.
2007-11-22
2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles
Grant 7,262,212 - Tsubouchi , et al. August 28, 2
2007-08-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed